---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-129777"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2024-12-18T23:59:59+00:00"
generated_at: "2026-05-29T01:59:06.951406+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# DarioHealth raises ~$18.8M via preferred stock; amends Avenue loan to extend maturity

## Summary
- Closed private placement of 7,055 Series D and 11,750 Series D-1 preferred shares at $1,000 each, raising $18.8M.
- Preferred stock convertible at $0.73/share, subject to stockholder approval and a 19.99% beneficial ownership blocker.
- Amended Avenue loan: extended interest-only period by 6 months, conditional on revenue milestone; maturity extended to Nov 1, 2027.
- Proforma cash balance of $34M as of Q3 2024; company targets profitability run-rate by end of 2025.

## SEC filing metadata
- accession: 0001104659-24-129777
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2024-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465924129777/0001104659-24-129777-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465924129777/tm2431382d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-129777
- JSON: https://secwatch.observer/filing/0001104659-24-129777.json
- Plain text: https://secwatch.observer/filing/0001104659-24-129777.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.